242 related articles for article (PubMed ID: 25800244)
61. Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A.
Nielsen SM; Rubinstein WS; Thull DL; Armstrong MJ; Feingold E; Yip L; Tisherman SA; Carty SE
Fam Cancer; 2011 Dec; 10(4):701-7. PubMed ID: 21713522
[TBL] [Abstract][Full Text] [Related]
62. Germline SDHD mutation in familial phaeochromocytoma.
Astuti D; Douglas F; Lennard TW; Aligianis IA; Woodward ER; Evans DG; Eng C; Latif F; Maher ER
Lancet; 2001 Apr; 357(9263):1181-2. PubMed ID: 11323050
[TBL] [Abstract][Full Text] [Related]
63. Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel-Lindau Syndrome.
Li SR; Nicholson KJ; Mccoy KL; Carty SE; Yip L
World J Surg; 2020 Feb; 44(2):570-577. PubMed ID: 31773218
[TBL] [Abstract][Full Text] [Related]
64. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
65. [Association of a pheochromocytoma and a homolateral clear cell renal carcinoma].
Satge D; Hassan T; Grande-Goburdhun J; Kantelip B; Pages A
Ann Pathol; 1991; 11(3):186-90. PubMed ID: 1878088
[TBL] [Abstract][Full Text] [Related]
66. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
67. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
[TBL] [Abstract][Full Text] [Related]
68. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
Galan SR; Kann PH
Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
[TBL] [Abstract][Full Text] [Related]
69. [Extra-adrenal pheochromocytoma associated to SDHD gene mutation].
Lendvai N; Szabó I; Butz H; Beko G; Horányi J; Tarjányi M; Alföldi S; Szabó I; Rácz K; Patócs A
Orv Hetil; 2009 Apr; 150(14):645-9. PubMed ID: 19318336
[TBL] [Abstract][Full Text] [Related]
70. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
71. Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome.
Panizza E; Ercolino T; Mori L; Rapizzi E; Castellano M; Opocher G; Ferrero I; Neumann HP; Mannelli M; Goffrini P
Hum Mol Genet; 2013 Feb; 22(4):804-15. PubMed ID: 23175444
[TBL] [Abstract][Full Text] [Related]
72. Recent advances in the diagnosis and treatment of pheochromocytoma.
Widimský J
Kidney Blood Press Res; 2006; 29(5):321-6. PubMed ID: 17119341
[TBL] [Abstract][Full Text] [Related]
73. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
74. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
[TBL] [Abstract][Full Text] [Related]
75. [The von Hippel-Lindau syndrome. Its differential diagnosis from cystic kidneys in adulthood].
Hauschild S; Feddersen A; Frahm C; Kreft B; Wallner SJ; Steinhoff J
Dtsch Med Wochenschr; 1995 Jun; 120(22):790-4. PubMed ID: 7781510
[TBL] [Abstract][Full Text] [Related]
76. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
77. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
[TBL] [Abstract][Full Text] [Related]
78. Homozygous TMEM127 mutations in 2 patients with bilateral pheochromocytomas.
Eijkelenkamp K; Olderode-Berends MJW; van der Luijt RB; Robledo M; van Dooren M; Feelders RA; de Vries J; Kerstens MN; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2018 May; 93(5):1049-1056. PubMed ID: 29282712
[TBL] [Abstract][Full Text] [Related]
79. Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease.
Jordan DK; Patil SR; Divelbiss JE; Vemuganti S; Headley C; Waziri MH; Gurll NJ
Cancer Genet Cytogenet; 1989 Oct; 42(2):227-41. PubMed ID: 2790758
[TBL] [Abstract][Full Text] [Related]
80. Von Hippel-Lindau syndrome with unusual presentations in two brothers.
Saranga R; Matzkin H; Papo J; Braf Z
Urology; 1989 Nov; 34(5):301-4. PubMed ID: 2815455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
